The implications of this can't be overstated. Control of samples is too important for other companies to not starting to suffer from FOMO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025